CoTherix submits Ventavis NDA

CoTherix (South San Francisco, Calif.) submitted an NDA to FDA for Ventavis iloprost inhaled prostacyclin analog to treat pulmonary arterial hypertension (PAH). In October 2003, CoTherix licensed excl...